Iovance Biotherapeutics
Iovance Biotherapeutics is a late-stage oncology company with the potential to bring the first novel autologous T cell therapy to the market for solid tumors in patients with significant unmet needs.
$123.0m
Money raised
Overview
Iovance Biotherapeutics is a late-stage oncology company with the potential to bring the first novel autologous T cell therapy to the market for solid tumors in patients with significant unmet needs.
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma**** Si*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Me***** Mc**** | - | - | - |
| At**** Co*********** | - | - | |
| Ry** Ma***** | - | - | - |
| Mi***** We**** | - | - | - |
Industries
Iovance Biotherapeutics is active in the following industries:
- Healthcare
- Therapeutics
- Biomedical engineering
- Pharmaceutical industry
- Cancer
- Oncology
- Cell therapy
- Immunotherapy
- Consumer biotechnology
- Engineering
- Technology
- Biology
- Biotechnology
- Internal medicine
- Regenerative medicine
- Medicine
- Genomics
- Genome editing
- Tissue engineering
- Life science